RRS HA Cellurix is a special cocktail intended for body mesotherapy, containing hyaluronic acid and ingredients that help break down stubborn fat and firm the skin. This preparation not only smoothes, but also shapes selected parts of the body - the caffeine and fucoxanthin it contains have a lipolytic effect. In addition, it is extremely rich in antioxidants and microelements that improve the quality of the skin and stimulate its repair processes. As a result, unevenness is smoothed out and the skin becomes taut and elastic.
RRS HA Cellutrix is a class III medical device - CE 1014 mark, intended for injection.
Effects:
- cellulite reduction
- firming the skin affected by cellulite
- reduction of locally accumulated fat tissue
- improving skin quality
Areas of application:
- buttocks
- back of thigh
- back
- Belly
Injection technique:
- spot every 2-3 cm,
- 0.3 ml per injection point,
- 10-30 ml can be used for one treatment,
- can be used as monotherapy or in combination with RRS Silisorg in a 1:1 ratio.
- Recommended needle size: 32G.
The preparation contains:
- 0.05 mg/ml HA hyaluronic acid 17.5 mg/ml biostimulating cocktail
- 8 antioxidants: vit.C, triferulic acid, Irbic acid, Isobenzofuranon, -hederin, Hederasaponin C, Hederacolchiside E and F
- 2 lipolytics: fucoxanthin, cafeine
- 7 flavonoids: cinaroside, cinaratrioside, quercetin, kaempferol, troxerutin, rutin, hesperidin
- 8 trace elements: I, K, Br, Cl, Ca, Fe, Si, Mg
- 3 vitamins: vit. C, vit. A, vit. B2
- 8 saponins: ruscogenins, neoruscogenin, α-hederin, hederasaponin C, hederacolchiside E and F, asiaticoside, madecassoside
- 3 triterpenes: asiatic acid, madecassic acid, succinic acid
- 1 amino acid: L-carnitine
- 2 AHAs: malic acid, lactic acid
- 2 polyphenols: chlorogenic acid, Phloroglucin
- lipolytic ingredient: caffeine and fucoxanthin
- fat transport: AHAs
Packaging:
- 1 vial x 10 ml of the preparation
Product for use by professionals only.
By deciding to purchase, you declare that you are a doctor or cosmetologist trained in aesthetic medicine.
